Shu Wan Kau

1.3k total citations
14 papers, 843 citations indexed

About

Shu Wan Kau is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Shu Wan Kau has authored 14 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Cancer Research and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Shu Wan Kau's work include Breast Cancer Treatment Studies (10 papers), Cancer Treatment and Pharmacology (8 papers) and Breast Lesions and Carcinomas (5 papers). Shu Wan Kau is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Cancer Treatment and Pharmacology (8 papers) and Breast Lesions and Carcinomas (5 papers). Shu Wan Kau collaborates with scholars based in United States, United Kingdom and Singapore. Shu Wan Kau's co-authors include Gabriel N. Hortobágyi, Aman U. Buzdar, Vicente Valero, Bryan T. Hennessy, S. Eva Singletary, Kristine Broglio, Bruno D. Fornage, Ayşegül A. Şahin, Nour Sneige and Roman Rouzier and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Shu Wan Kau

14 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shu Wan Kau United States	12	633	453	418	155	129	14	843
Vincenzo Delledonne Italy	10	624 1.0×	239 0.5×	601 1.4×	251 1.6×	282 2.2×	13	920
Günther Raab Germany	8	465 0.7×	394 0.9×	210 0.5×	87 0.6×	23 0.2×	10	605
Sigvard Kaae Denmark	14	285 0.5×	305 0.7×	183 0.4×	125 0.8×	39 0.3×	33	714
Pamela H. Craig United States	8	790 1.2×	370 0.8×	684 1.6×	248 1.6×	97 0.8×	10	965
Debbie Frye United States	8	373 0.6×	396 0.9×	126 0.3×	60 0.4×	21 0.2×	13	556
A. Catturich Italy	15	532 0.8×	262 0.6×	417 1.0×	298 1.9×	36 0.3×	31	683
S. Giard France	20	982 1.6×	469 1.0×	663 1.6×	428 2.8×	41 0.3×	66	1.2k
A.H. Tulusan Germany	9	452 0.7×	387 0.9×	210 0.5×	96 0.6×	17 0.1×	22	637
Sabine Schmatloch Germany	9	1.0k 1.6×	523 1.2×	731 1.7×	511 3.3×	39 0.3×	32	1.2k
David D. Paulus United States	8	465 0.7×	296 0.7×	373 0.9×	114 0.7×	46 0.4×	16	685

Countries citing papers authored by Shu Wan Kau

Since Specialization

Citations

This map shows the geographic impact of Shu Wan Kau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Wan Kau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Wan Kau more than expected).

Fields of papers citing papers by Shu Wan Kau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Wan Kau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Wan Kau. The network helps show where Shu Wan Kau may publish in the future.

Co-authorship network of co-authors of Shu Wan Kau

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Wan Kau. A scholar is included among the top collaborators of Shu Wan Kau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Wan Kau. Shu Wan Kau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Hennessy, Bryan T., Ana M. González-Angulo, Gabriel N. Hortobágyi, et al.. (2006). Disease‐free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy. Cancer. 106(5). 1000–1006. 40 indexed citations

Hennessy, Bryan T., Savitri Krishnamurthy, Sharon H. Giordano, et al.. (2005). Squamous Cell Carcinoma of the Breast. Journal of Clinical Oncology. 23(31). 7827–7835. 147 indexed citations

Hennessy, Bryan T., Gabriel N. Hortobágyi, Roman Rouzier, et al.. (2005). Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy. Journal of Clinical Oncology. 23(36). 9304–9311. 319 indexed citations

Resetkova, Erika, Ana M. Gonzalez‐Angulo, Nour Sneige, et al.. (2004). Prognostic value of P53, MDM‐2, and MUC‐1 for patients with inflammatory breast carcinoma. Cancer. 101(5). 913–917. 18 indexed citations

Buzdar, Aman U., Shu Wan Kau, Gabriel N. Hortobágyi, et al.. (1994). Phase I trail of droloxifene in patients with metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 33(4). 313–316. 24 indexed citations

Holmes, Frankie A., Aman U. Buzdar, Shu Wan Kau, et al.. (1994). Combined-modality approach for patients with isolated recurrences of breast cancer (IV-NED). The M. D. Anderson experience. 7(1). 7–20. 30 indexed citations

Krakoff, Irwin H., Aman U. Buzdar, Shu Wan Kau, et al.. (1994). Phase I trial of droloxifene in patients with metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 33(4). 313–316. 1 indexed citations

Buzdar, Aman U., Shu Wan Kau, Gabriel N. Hortobágyi, et al.. (1993). The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer. Cancer. 71(11). 3680–3684. 48 indexed citations

Buzdar, Aman U., Marsha D. McNeese, Gabriel N. Hortobágyi, et al.. (1990). Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?. Cancer. 65(3). 394–399. 49 indexed citations

10.

Buzdar, Aman U., Shu Wan Kau, Terry L. Smith, & Gabriel N. Hortobágyi. (1989). Ten-Year Results of FAC Adjuvant Chemotherapy Trial in Breast Cancer. American Journal of Clinical Oncology. 12(2). 123–128. 56 indexed citations

11.

Hortobágyi, Gabriel N., et al.. (1989). Sequential cyclic combined hormonal therapy for metastatic breast cancer. Cancer. 64(5). 1002–1006. 11 indexed citations

12.

Hortobágyi, Gabriel N., Hwee‐Yong Yap, Shu Wan Kau, et al.. (1989). A Comparative Study of Doxorubicin and Epirubicin in Patients with Metastatic Breast Cancer. American Journal of Clinical Oncology. 12(1). 57–62. 69 indexed citations

13.

Buzdar, Aman U., Gabriel N. Hortobágyi, Terry L. Smith, et al.. (1988). Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs. Cancer. 62(10). 2098–2104. 22 indexed citations

14.

Hortobágyi, Gabriel N., Shu Wan Kau, Frankie A. Holmes, et al.. (1988). Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer. Cancer. 62(10). 2105–2110. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact